SCHEMBL20739715

SCHEMBL20739715

C=CCc1ccc(OCCCCCCCC)c(OC)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.68
ALDH1A1 P00352 7/20 0.68
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
PPARG P37231 1/20 0.67
PPARD Q03181 1/20 0.67
MAPT P10636 4/20 0.63
TDP1 Q9NUW8 1/20 0.63
KDM4E B2RXH2 4/20 0.60
LMNA P02545 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
GAA P10253 2/20 0.60
HTT P42858 1/20 0.60
NPC1 O15118 3/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
CNR2 P34972 1/20 0.57
TSHR P16473 2/20 0.56
RAB9A P51151 2/20 0.56
TP53 P04637 1/20 0.56
MAPK1 P28482 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20739714 1.00 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL573784 1.00 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL11837062 1.00 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL20723736 1.00 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL20739716 1.00 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL20723798 1.00 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL20723695 1.00 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL357725 0.99 PPARA (0.70) PPARAALDH1A1MEN1KMT2APPARG
Hydrochloric Acid SCHEMBL29175090 0.97 PPARA (0.68) PPARAALDH1A1MEN1KMT2APPARG
N-Butyleugenol SCHEMBL18035642 0.94 ALDH1A1 (0.71) PPARAALDH1A1MEN1KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019030643-A1 COMPOSITIONS OF EUGENOL DERIVATIVES FOR TREATMENT OF VISCERAL LEISHMANIASIS FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2019-02-14 WO disclosed